INS and Alzheimer disease: It has been shown that insulin signaling is reduced in the brains of patients with AD, known as cerebral insulin resistance, and is related to the accumulation of beta-amyloid plaques and the formation of neurofibrillary tangles (Michailidis et al., 2022).